NCT00494585View on ClinicalTrials.gov

CEP-701 for PH-negative Myelofibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

LeukemiaMyelofibrosis

Interventions

DRUG

CEP-701

80 mg orally twice a day for 30 days

Trial Locations (1)

77030

The University of Texas M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Cephalon

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER